Cited by 242Salmonella and Campylobacter epidemiologyTravel-related health issuesViral gastroenteritis research and epidemiology

Use of Azithromycin for the Treatment of Campylobacter Enteritis in Travelers to Thailand, an Area Where Ciprofloxacin Resistance Is Prevalent

Kuschner, R. A., Trofa, A. F., Thomas, R. J., Hoge, C. W., Pitarangsi, C., Amato, S., Olafson, R. P., Echeverria, P. +2 more·1995·Clinical Infectious Diseases

Abstract

We evaluated the use of azithromycin (500 mg) or ciprofloxacin (500 mg) daily for 3 days for the treatment of acute diarrhea among United States military personnel in Thailand. Stool cultures were obtained and symptoms were recorded on study days 0, 1, 2, 3, and 10. Campylobacter species were the most common pathogen isolated (44 isolates from 42 patients). All Campylobacter isolates were susceptible to azithromycin; 22 were resistant to ciprofloxacin. Among the 42 patients with campylobacter infection, there were 2 clinical and 6 bacteriologic treatment failures in the ciprofloxacin group and no treatment failures in the azithromycin group (P = .021 for bacteriologic failures). Overall, azithromycin was as effective as ciprofloxacin in decreasing the duration of illness (36.9 hours vs. 38.2 hours, respectively) and the number of stools (6.4 vs. 7.8, respectively). Among those not infected with Campylobacter species (n = 30), the duration of illness was 32.9 hours vs. 20.7 hours (P = .03) for the azithromycin and ciprofloxacin groups, respectively. Azithromycin is superior to ciprofloxacin in decreasing the excretion of Campylobacter species and as effective as ciprofloxacin in shortening the duration of illness. Azithromycin therapy may be an effective alternative to ciprofloxacin therapy in areas where ciprofloxacin-resistant Campylobacter species are prevalent.

Integrity signals

Registry

Crossref · 10.1093/clinids/21.3.536

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Yersinia has symptoms similar to those of acute appendicitis, necessitating differential diagnosis.

    “Yersinia has symptoms similar to those of acute appendicitis, thus necessitating differential diagnosis [78].”

    From Guideline for the Antibiotic Use in Acute Gastroenteritis (2019) · cites this paper as [78]

  • For food-related outbreaks, the possible pathogen can be estimated based on the incubation period: 1-6 hours suggests S. aureus or Bacillus cereus producing emetic toxin; 8-16 hours suggests C. perfringens or B. cereus producing diarrheal toxin; and 16-72 hours suggests ETEC, Salmonella, Shigella, and Vibrio cholerae.

    “Short incubation periods of 1 - 6 hours are estimated to have been caused by consumption of toxins, so S. aureus or Bacillus cereus producing emetic toxin is suspected. C. perfringens or B. cereus producing diarrheal toxin are suspected for incubation periods of 8 - 16 hours, and Enterotoxigenic E. coli (ETEC), Salmonella, Shigella, and Vibrio cholerae may be suspected for incubation periods of 16”

    From Guideline for the Antibiotic Use in Acute Gastroenteritis (2019) · cites this paper as [78]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kuschner, R. A., Trofa, A. F., Thomas, R. J., Hoge, C. W., Pitarangsi, C., Amato, S., Olafson, R. P., Echeverria, P., Sadoff, J. C., & Taylor, D. N.
Affiliations
Armed Forces Research Institute of Medical Science (TH)
Corresponding author
Kuschner, R. A.
Venue
Clinical Infectious Diseases
Published
1995-09-01
Volume
21
Issue
3
Pages
536-541
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W1964400832
Cited by
242
References
36
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 5 · 2017: 8 · 2016: 6 · 2015: 6 · 2014: 8 · 2013: 4 · 2012: 5
FWCI
14.94
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Department of Defense
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
  • Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
Keywords
campylobacteriosis, azithromycin, ciprofloxacin, ciprofloxacin resistance, acute diarrhea, traveler's diarrhea, military personnel, Thailand, antibiotic treatment failure, disease duration
MeSH terms
Adult, Anti-Infective Agents, Anti-Bacterial Agents, Campylobacter, Campylobacter Infections, Ciprofloxacin, Diarrhea, Double-Blind Method, Drug Resistance, Microbial, Enteritis, Female, Humans, Male, Military Personnel, Thailand, Travel, United States, Azithromycin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review